FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.



More Latest News

Board Chairs/Vice Chairs Annual Long-range Planning Meeting
January 10, 2018

The Annual Long Range Planning meeting has been rescheduled for Monday, April 23, 2018. Please click here for more information. Continue reading


Florida Board of Pharmacy – New Members Appointed
December 13, 2017

Please click for details regarding new members of the Board of Pharmacy appointed by Governor Scott. Continue reading